Hannah Weber joins biodefense panel at DARPA and Ferocity Capital summit during J.P. Morgan Healthcare Conference
Jan 13, 2026
Hannah Weber, Co-Founder and Vice President of Strategy & Business Development at HOPO Therapeutics, participated in panel of BARDA and DARPA-funded startup founders at the DARPA + Ferocity Capital Biodefense Summit, held during the 2026 J.P. Morgan Healthcare Conference in San Francisco. The summit brought together investors, company leaders, researchers, and policymakers to discuss the future of biodefense and biosecurity innovation.
